Antimicrobial Effect of Cannabidiol on Intracellular Mycobacterium tuberculosis
- 22 January 2024
- journal article
- research article
- Published by SAGE Publications in Cannabis & Cannabinoid Research
- Vol. 9 (2) , 464-469
Abstract
Introduction: Mycobacterium tuberculosis , the etiologic agent of tuberculosis (TB), has killed nearly one billion people during the last two centuries. Nowadays, TB remains a major global health problem ranked among the top 10 causes of death worldwide. One of the main challenges in developing new strategies to fight TB is focused on reducing the duration and complexity of drug regimens. Cannabidiol (CBD) is the main nonpsychoactive ingredient extracted from the Cannabis sativa L . plant, which has been shown to be biologically active against bacteria. The purpose of this work was to investigate the antimicrobial effect of CBD on M. tuberculosis intracellular infection. Materials and Methods: To assess the minimum inhibitory concentration (MIC) of CBD on mycobacterial strains, the MTT assay was performed on Mycobacterium smegmatis , and the Colony-Forming Unit (CFU) assay was conducted on Mtb H37Rv. Additionally, the cytotoxic effect of CBD on THP-1 cells was assessed by MTT assay. Moreover, macrophages derived from the THP-1 cell were infected with Mtb H37Rv (multiplicity of infection 1:10) to evaluate the intracellular activity of CBD by determining the CFU/mL. Results: Antimicrobial activity against M. smegmatis (MIC=100 μM) and Mtb H37Rv (MIC=25 μM) cultures was exhibited by CBD. Furthermore, the effect of CBD was also evaluated on Mtb H37Rv infected macrophage cells. Interestingly, a reduction in viable intracellular Mtb H37Rv bacteria was observed after 24 h of treatment. Moreover, CBD exhibited a safe profile toward human THP-1 cells, since it showed no toxicity (CC 50 =1075 μM) at a concentration of antibacterial effect (selectivity index 43). Conclusion: These results extend the knowledge regarding the antimicrobial activity of CBD and demonstrate its ability to kill the human intracellular pathogen M. tuberculosis.Keywords
This publication has 21 references indexed in Scilit:
- Analysis of the clinical antibacterial and antituberculosis pipelineThe Lancet Infectious Diseases, 2019
- Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory functionTranslational Psychiatry, 2018
- Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact DermatitisThe Journal of Pharmacology and Experimental Therapeutics, 2018
- Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophagesFitoterapia, 2016
- Anti-Inflammatory Role of Cannabidiol and O-1602 in Cerulein-Induced Acute Pancreatitis in MicePancreas, 2013
- Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial CellsJournal of Biological Chemistry, 2010
- Cannabidiol arrests onset of autoimmune diabetes in NOD miceNeuropharmacology, 2008
- Chemical constituents of marijuana: The complex mixture of natural cannabinoidsLife Sciences, 2005
- In vitro antiplasmodial activity and cytotoxicity of ethnobotanically selected Ivorian plantsJournal of Ethnopharmacology, 2003
- Antibacterial activity of Δ9-tetrahydrocannabinol and cannabidiolAntonie van Leeuwenhoek, 1976